It is worth noting that MLL1 rearranged ALL (MLL1 r ALL) is highly prevalent, affecting more than 80% of ALL diagnoses in infants under one year old, approximately 5–6% in pediatric patients, and around 15% in adults [1, 8]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.